Sign in
Taking peopleNo phase

Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia

Key facts

Who runs it
luxia Kong
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
3 Dec 2024
Planned end
30 Sept 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Fecal Microbiota Transplantation
Record updated
3 December 2024

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (16)Hide the full registry criteria

Who can take part

  • Age 18-75
  • Meet the diagnostic criteria for community-acquired pneumonia or hospital-acquired pneumonia
  • The etiological results of sputum or alveolar lavage fluid suggested MDR-KP infection
  • The patient or his family members voluntarily participated, collected alveolar lavage fluid and stool samples, agreed to perform FMT treatment, and signed the informed consent

Who cannot take part

  • Those who have recently been treated with high-risk immunosuppressive/cytotoxic drugs, such as rituximab, doxorubicin, or steroid hormones (20mg/d ponisone or higher) for more than 4 weeks
  • Patients with severe damage of intestinal barrier such as sepsis and digestive tract perforation due to various reasons
  • Those currently diagnosed with explosive colitis or toxic megacolon have gastroesophageal reflux disease or peptic ulcer; Subjects taking probiotics within 6 months
  • Enteral nutrition patients who could not tolerate 50% of heat calorie requirements due to severe diarrhea, significant fibrous intestinal stenosis, severe gastrointestinal bleeding, high-flow intestinal fistula and other reasons
  • Patients with obvious bleeding tendency, severe pulmonary hypertension, superior vena cava obstruction, and aortic aneurysm rupture risk
  • Patients with malignant hypertension, recent myocardial infarction (≤6 months), severe arrhythmia, and cardiac insufficiency
  • suffering from malignant tumor diseases, congenital or acquired immune deficiency diseases, other systemic inflammatory response diseases
  • There is a mental disability or active mental illness that prevents informed consent
  • Conditions deemed unsuitable for study inclusion by other clinicians
  • Severe immunosuppression: adult neutrophils <1 500/mm3, child neutrophils <1 000/mm3
  • Subjects with persistent bronchial asthma, severe pulmonary dysfunction, or inability to tolerate bronchoscopy
  • Pregnancy or lactation

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Klebsiella pneumoniae pneumonia

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections account for 10% of all nosocomial infections, and even with effective antibiotics, the mortality rate is as high as 50%. Intestinal bacteria transplantation can not only treat intestinal diseases, but also inhibit the colonization and proliferation of drug-resistant bacteria. This study explored the therapeutic value of fecal microbiota transplantation in patients with MDR-KP pneumonia.

The 2 groups in the trial

  • experimental groupTreatment being tested

    This group of patients received conventional antibiotic therapy and fecal microbiota transplantation.

    Treatment: Fecal Microbiota Transplantation

  • control groupNo study treatment, for comparison

    Patients in this group were treated with conventional antibiotics.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06641778, who can take part
Record updated
3 December 2024